Enteric fever, commonly known as typhoid fever, is a potentially fatal multisystemic illness primarily caused by Salmonella Typhi and Salmonella Paratyphi. Despite advancements in healthcare, it remains a significant public health concern, especially in developing countries. This article aims to review recent advancements in the diagnosis and treatment strategies for enteric fever.
Early and accurate diagnosis of enteric fever is crucial for effective management. Traditional methods like blood culture have limitations such as time consumption and low sensitivity. Recent advancements include molecular techniques like PCR (Polymerase Chain Reaction) and Nucleic Acid Amplification Tests (NAATs) that offer high sensitivity and specificity. Additionally, serological tests such as Typhidot and Tubex TF have shown promise in early detection.
Antibiotic therapy remains the cornerstone of enteric fever treatment. However, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains poses a significant challenge. Therefore, the focus has shifted towards newer antibiotics like azithromycin and third-generation cephalosporins. Moreover, the use of fluoroquinolones, despite resistance concerns, still plays a role in managing uncomplicated cases.
Prevention is always better than cure. In this regard, the development and implementation of effective vaccines such as Vi polysaccharide vaccine (Typhim Vi) and typhoid conjugate vaccine (Typbar-TCV) have shown significant potential in controlling the spread of enteric fever. These vaccines have demonstrated good safety profiles and high efficacy rates.
In conclusion, the management of enteric fever has seen significant advancements in recent years. Diagnostic techniques have evolved to provide quicker and more accurate results. Treatment strategies have adapted to the challenge of antibiotic resistance, and vaccines have been developed to prevent the disease. However, continuous research and development is essential to stay ahead of the evolving pathogen and ensure effective control of enteric fever.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation